SEC’s Cox to Undergo Surgery for Tumor
From Reuters
Securities and Exchange Commission Chairman Christopher Cox, 53, will have surgery Monday to remove a thymoma, a tumor of the lymphatic system, the agency said.
In an e-mail to commission staff, Cox said he was expected to make a full recovery and planned to return to the office in two weeks. The thymus is part of the lymphatic system and makes white blood cells.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
